Blastic plasmacytoid dendritic cell neoplasia (BPDCN) is an aggressive hematologic malignancy originating from immature plasmacytoid dendritic cell (PDC) precursors. The initial manifestation of BPDCN often consists of cutaneous lesions. In this educational article, the clinical, histologic and therapeutic aspects of BPDCN are discussed from a dermatologic perspective.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Case study
Wiedemann-Steiner syndrome in a 2-year-old girl
- Chronic back pain
Care in the virtual hospital – the Back@home project
- Psoriatic arthritis
Long-term remission also possible without DMARDs
- Clinical relevance, benefits and limitations
Atrial Fibrillation Screening
- Parkinson's disease: progressive and clinically heterogeneous
Individualized management of motor and non-motor symptoms
- Type 2 diabetes and heart failure: a bidirectional relationship
Proactive preventive measures can reduce the burden of disease
- Dementia
Delirium risks and treatment strategies
- Colorectal cancer screening